Naxdu 20 Tablet
By Naxdu
Rx
10 Tablet in a Strip

Composition
Duloxetine(20mg)

Manufacturer - Anax Lifescience
11,Anax Life science, Purshotamnagar, Nr. Pink City, Ranip, Ahmedabad-382480

Expires on or after
October, 2025

liver
According to the information provided, Naxdu 20 Tablet may not be safe for individuals with liver disease and should be avoided. It is important to notify your doctor if you have any existing liver conditions before using Naxdu 20 Tablet. Your doctor will then assess the advantages and possible risks before deciding if this medication is suitable for you. It is advised to seek medical advice before using Naxdu 20 Tablet in case of liver problems.

kidney
Naxdu 20 Tablet should be used carefully in severe kidney disease, as dose adjustment might be necessary. Consult your doctor for guidance. Mild to moderate kidney disease may not require dose adjustment with Naxdu 20 Tablet. Naxdu 20 Tablet is not recommended for severe kidney disease.

alcohol
It is not safe to drink alcohol while using Naxdu 20 Tablet. Mixing alcohol with this medication can lead to increased side effects like confusion, drowsiness, and difficulty concentrating. Limit alcohol intake while taking this medicine.

driving
When taking Naxdu 20 Tablet, be cautious as it may reduce alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects to ensure safety on the road. Naxdu 20 Tablet can also cause sleepiness, impacting driving ability.

pregnancy
Naxdu 20 Tablet should not be used during pregnancy as it may have harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it. Consult your doctor before using Naxdu 20 Tablet.

breastfeeding
Naxdu 20 Tablet may not be safe for use while breastfeeding. Limited data suggests it could pass into breastmilk and harm the baby. Consult your doctor to determine if Naxdu 20 Tablet is suitable for nursing mothers.
Habit Forming | No |
Chemical Class | Naphthalene Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Serotonin-norepinephrine reuptake inhibitors (SNRIs) |
₹99
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024